Published online May 16, 2021. doi: 10.12998/wjcc.v9.i14.3308
Peer-review started: November 12, 2020
First decision: January 23, 2021
Revised: January 30, 2021
Accepted: March 10, 2021
Article in press: March 10, 2021
Published online: May 16, 2021
Processing time: 167 Days and 18.1 Hours
Endoscopic ultrasonography-guided fine-needle aspiration (EUS-FNA) is a safe and accurate technique to confirm the diagnosis of pancreatic cancers. The best cytological method for EUS-FNA in pancreatic lesions is controversial.
Recently, numerous studies comparing the diagnostic efficacy of smear cytology (SC) and liquid-based cytology (LBC) for pancreatic lesions yielded mixed results.
To compare and identify the better cytology method for EUS-FNA in pancreatic lesions.
A comprehensive search of PubMed, Embase, and Cochrane was undertaken through July 18, 2020.
Data on a total of 1121 comparisons from 10 studies met the inclusion criteria. Pooled rates of sensitivity for SC and LBC were 78% (67%-87%) vs 75% (67%-81%), respectively. In any case, both SC and LBC exhibited a high specificity close to 100%. Inadequate samples more often appeared in LBC compared with SC. However, the LBC samples exhibited a better visual field than SC. Very few post procedure complications were observed.
For EUS-FNA in pancreatic lesions (particularly solid lesions), SC with Rapid On-Site Evaluation (ROSE) represents a superior diagnostic technique. If ROSE is unavailable, LBC may replace smears. The diagnostic accuracy of LBC depends on different LBC techniques.
The need for more staff and material resources has limited the use of ROSE in some institutions. It makes sense to evaluate the diagnostic performance of different LBC methods for EUS-FNA in pancreatic lesions.
